⌘K
Loading ticker…
As of 2026-08-24, TRONOX LIMITED CL A ORDINARY SHARES (TROX) has a 3-month relative strength percentile of 15 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.5%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TROX is held by 14 ETFs as of May 2026. Top owner: AVUV at 0.10% weight, $26M notional. Top 3 carry $34M.
Held by 29 ETFs · $117M across latest filings · largest weight 1.67% (HYP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.10% | $26M | +0.03 pp |
| VTWO | 0.03% | $5M | — |
| VAWVanguard Materials ETF | 0.06% | $3M | — |
| AVSC | 0.07% | $2M | — |
| VFMO | 0.10% | $2M | new |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $1M |
| −0.05 pp |
| VTWV | 0.06% | $745K | — |
| ISMD | 0.14% | $440K | −0.19 pp |
| AVUSAvantis U.S. Equity ETF | 0.00% | $355K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $76K | — |
Showing 10 of 14 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TROX Jan avg: 17.45% median: 13.54% win: 75% σ: 22.19% n: 4 2022-04-12 → 2026-07-31 | TROX Feb avg: -0.86% median: -1.22% win: 50% σ: 20.56% n: 4 2022-04-12 → 2026-07-31 | TROX Mar avg: 7.89% median: 5.10% win: 50% σ: 19.67% n: 4 2022-04-12 → 2026-07-31 | TROX Apr avg: -7.34% median: -4.80% win: 20% σ: 9.73% n: 5 2022-04-12 → 2026-07-31 | TROX May avg: -3.28% median: 4.71% win: 60% σ: 17.19% n: 5 2022-04-12 → 2026-07-31 | TROX Jun avg: -7.91% median: -10.74% win: 20% σ: 16.50% n: 5 2022-04-12 → 2026-07-31 | TROX Jul avg: -8.78% median: -7.08% win: 40% σ: 16.75% n: 5 2022-04-12 → 2026-07-31 | TROX Aug avg: 4.18% median: -1.82% win: 50% σ: 21.09% n: 4 2022-04-12 → 2026-07-31 (current) | TROX Sep avg: -4.70% median: -3.77% win: 25% σ: 8.96% n: 4 2022-04-12 → 2026-07-31 | TROX Oct avg: -13.15% median: -15.05% win: 0% σ: 8.02% n: 4 2022-04-12 → 2026-07-31 | TROX Nov avg: 13.79% median: 18.02% win: 75% σ: 9.32% n: 4 2022-04-12 → 2026-07-31 | TROX Dec avg: -1.99% median: -1.12% win: 50% σ: 11.51% n: 4 2022-04-12 → 2026-07-31 |